| Tag | Content |
|---|
EnhancerAtlas ID | HS127-16691 |
Organism | Homo sapiens |
Tissue/cell | Macrophage |
Coordinate | chr2:61022160-61024190 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| HNF4G | MA0484.1 | chr2:61023668-61023683 | TAAGTACAAAGTTCA | + | 6.32 | | Nr2f6(var.2) | MA0728.1 | chr2:61023492-61023507 | TGAACTCCTGACCTC | - | 6.22 | | SPI1 | MA0080.4 | chr2:61023849-61023863 | AACTTCCTTTTTTT | - | 6.11 | | Sox3 | MA0514.1 | chr2:61022402-61022412 | CCTTTGTTTT | + | 6.02 | | Stat6 | MA0520.1 | chr2:61023683-61023698 | GTTTTCCTGAGAACT | + | 7.39 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_60097 | chr2:61021478-61072429 | Ly4 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I060795 | chr2 | 61023093 | 61024769 |
|
Enhancer Sequence | AAGATAGTCT TGTTCATAGG TACAGTACAT AGGTAAAAAC TCATAGGTAA TCTACAAGTA 60
CAAAAGGCTT ATTAAGAGCC TAGCACTGGG AAAAAGTAAG ATTTTGTCCC TGTCCCCAAG 120
GACTAGCAGT GTAGTTGGGG TTGGAGATAG CAAGTATATA GTTCTGAATG TATGTACCTC 180
AAAAGTCTAA AAAAGAGGCA GTAGTTTAAG ACAACTTTAT TATCTATTTA GATTATGTTC 240
ACCCTTTGTT TTTTATCTTT AAAGAAGCAG TTGGATGCTC AGCACATTAA TTTCTTACCA 300
AGCACCTGGA GGTATATCTC TGTTGTGTAC TATTGCTTAC TGCCAAAACA TAGGTTTGAT 360
AATTAGGAAC CATATGTATT AATATTTTAG AGGAACCAAA TGTAGTGGTA TATATAGTAA 420
GTACCTTTAA AACATGAGCT AAACGCCCCT AAATTGTAAT TTAAATGTTT ATTATTTGAA 480
GAATTACTTT TATAACTAAA AATGTGTGTA GTATTAAGTG TGGTATGCTA AAAAGCAAGT 540
ACTCAAAAAC CAGCCTTGTG TAAATAGAGA AAAACCTTCT CTGAGAGTTT ATAATGAACA 600
GAATGGCTTA TTTATAATAA TGATAAATAA TTATAAATAT ATATGATGAT AATTATAAAT 660
TATAATTTAT AATAAAACAG AATGGCCATT AAATAGTAAA GTGCTTTTCA TCAACTGTTA 720
CCCTGCCAGG TTCTCCAGGA TGTAGTAGCT ATTCTAAAGC AAAATAGTAT ACTCACAGGC 780
TATTAGTTGT AGATTTTGAG CCTTTAACAT AAGATTAAGT TACAAAAAAT ATGAACGTAT 840
AATTATGTGT CATGGTGGAA GAAAAAATTT TGAGATGGAT ATTGAAGTAC AAAAGAGTGA 900
AATGACATAT CTGGATTTTT TAATATATCC AGTCTAAAGG GAAAGTGGGT ACACCAAACA 960
ATTGCAGCAA AATTGTAATA ATGTCTGAAA CTTGGTTTTG GCATTTAAGT CCTTATTGCC 1020
CTGGTGTCTA CTTCTTTGTA TATCTGAAAT TGCTCATAAT TGTTTTAATG CATATGGATA 1080
TGATACAGAT ACTGGCTTAG CCAAGGTAAA ACAAGAGGAG AATTAAGCAG TCATCTCTTG 1140
ACAAGAAACT ATCCCCATTA CAGAAGTCTA GATTTTGCCT TCCTTTTTTT TTTTTTTTTT 1200
TTTTTTTTTG GACATGGAGG CTCGCTCTGT AGCCCAGGTT GGAGTGCAAT GGCGCGATCT 1260
TTTTGTATTT GTAGTGGCTA ATTTTTGTAT TTGTAGTGGA AAAGGGTTTC ACCATATTGG 1320
CCAGGCTGCT CTTGAACTCC TGACCTCAAG TGATTCGCCC GCCTTGGCCT CCCAAAGTTC 1380
TGGGATTACA GGCGTGAACC ACCATGCCCG GCCCTAGATT TTGCCTTCTT TATGTAATAA 1440
TCTTTAATGC CCTCAGAATC CCTCAAACCG ATGTCCCTGA ATTTCATAAC CATCAAAGTT 1500
ATCTAGCCTA AGTACAAAGT TCAGTTTTCC TGAGAACTTA AGTATCTCAC AGATTGAGTC 1560
AGTGGTCTTC TTCATGAATG TATTACAGAA ACAAATTGAG GGACATAACT CTCAGATATT 1620
AAATTTTTCT CTACTGCACA CACTCATTTT TCACTTCACA CCCCAAGAGC TTCCTGTTTA 1680
GTCACCATGA ACTTCCTTTT TTTTTTCTTT GCTTGACCTT AAGGACTGTG TTCTTTATGC 1740
ATTTCTTGAT CCAGGCATGG CAGTTCCTCT TTTCCTGTAC ATATTCACAC TCCTGCCACT 1800
TCTACCCTTT CTCTTATCCC TCTGCTTTTC ACCTCTGACT GTAAAAAGAA GTAGCAGTTC 1860
CGAAAGCAAG AGTTCCCTAT GAACACGGAA GGAAATATTC ATTGCATACT TGAGTGTTTA 1920
GGAGCTAGAG GGTTTGGGAG AAAAACTCCC CAAGTTTTGT GACTGACTTT CTAGCTGGGC 1980
CTTTATAATA TATATGATGT GCTTTTCCTT TTTTGTTTCC TCTTTCTTTC 2030
|
